Major Adverse Effects Associated with Tacrolimus (Fk506) Based Regimen among Saudi Kidney Transplant Patients
Ahmed S. Ali, Marzog S. Al-Nasser, Mai A. Abdul Sattar, Huda M. Alkreathy, Mohammed N. Al-Amma, Rayan A. Alsulaimani & Ezz H. Abdulfattah · Journal of Pharmaceutical Research International · 2018
Tacrolimus (Fk506)- based immunosuppressant regimen has become the cornerstone in managing kidney transplant patients (KTP) , where it has been used typically used on chronic basis. However, various adverse effects on multiple organ systems are expected and their incidence is dep...
Open access
Research Article
10.9734/JPRI/2018/41611